https://www.selleckchem.com/pr....oducts/Roscovitine.h
Kai-Xin-San (KXS) has been used to treat Alzheimer's disease (AD) for thousands of years. However, no quantitative data regarding AD treatment using KXS are available. Moreover, its active compounds and mechanism of action for the treatment of AD remain largely unclear. To evaluate the efficacy and the potential pharmacological mechanisms of KXS in AD treatment. A systematic collection of KXS experiments was conducted from PubMed, Web of Science, Embase, CNKI, VIP, and Wanfang Data up to February, 2020. Review Manager 5 software was
Like
Comment
Share
